Kimberlin DW. Real-World Data on Cutaneous Recurrences Following Neonatal Herpes Simplex Virus Disease.
J Pediatric Infect Dis Soc 2022;
11:504-505. [PMID:
36264543 DOI:
10.1093/jpids/piac110]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Accepted: 10/19/2022] [Indexed: 11/14/2022]
Abstract
Though primarily used to improve neurodevelopmental outcomes, suppressive oral acyclovir therapy following neonatal herpes simplex virus disease also decreases cutaneous recurrences. Skin recurrences can still occur, however, and understanding their frequency is helpful in managing patients with this rare disease.
Collapse